AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rrufff who wrote (501)	3/3/2006 1:40:08 PM
From: Hawkmoon	Read Replies (1) of 513

AVAN appears to be getting ready for a major move. There is a 20WeekMA crossover underway, preparing to break north of the 200WeekMA. bigcharts.marketwatch.com Not quite sure if earnings on Wednesday will be the catalyst that drives this, but certainly having Glaxo provide is $40 million in royalties for Rotarix is likely to help the stock tremendously. The hourly chart would seem to indicate that it's "rolling over" short-term, but I see that the 20HourMA average has crossed north of the 50HourMA, and should provide support at $2/share and provide a springboard for more upside. bigcharts.marketwatch.com Thanks for the tip rruff.. I think you're on to something here. Hawk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next